Neurobiomarker and body temperature responses to recreational marathon running.

Brain injuries, traumatic Copeptin GFAP protein, human Heat illness Heat stroke Ubiquitin carboxyl-terminal hydrolase L-1, human

Journal

Journal of science and medicine in sport
ISSN: 1878-1861
Titre abrégé: J Sci Med Sport
Pays: Australia
ID NLM: 9812598

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 28 04 2023
revised: 11 09 2023
accepted: 17 09 2023
medline: 27 11 2023
pubmed: 1 10 2023
entrez: 30 9 2023
Statut: ppublish

Résumé

To assess how biomarkers indicating central nervous system insult (neurobiomarkers) vary in peripheral blood with exertional-heat stress from prolonged endurance exercise. Observational study of changes in neuron specific enolase (NSE), S100 calcium-binding protein B (S100β), Glial Fibrillary Acid Protein (GFAP) and Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1) at Brighton Marathon 2022. In 38 marathoners with in-race core temperature (Tc) monitoring, exposure (High, Intermediate or Low) was classified by cumulative hyperthermia - calculated as area under curve of Time × Tc > 38 °C - and also by running duration (finishing time). Blood was sampled for neurobiomarkers, cortisol and fluid-regulatory stress surrogates, including copeptin and creatinine (at rested baseline; within 30 min of finishing; and at 24 h). Finishing in 236 ± 40 min, runners showed stable GFAP and UCH-L1 across the marathon and next-day. Significant (P < 0.05) increases from baseline were shown post-marathon and at 24 h for S100β (8.52 [3.65, 22.95] vs 39.0 [26.48, 52.33] vs 80.3 [49.1, 99.7] ng·L Successful marathon performance did not associate with evidence for substantial neuronal insult. To account for variation in neurobiomarkers with prolonged endurance exercise, factors additional to hyperthermia, such as exercise duration and intensity, should be further investigated.

Identifiants

pubmed: 37777396
pii: S1440-2440(23)00412-7
doi: 10.1016/j.jsams.2023.09.011
pii:
doi:

Substances chimiques

Creatinine AYI8EX34EU
Hydrocortisone WI4X0X7BPJ
Biomarkers 0

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

566-573

Informations de copyright

Crown Copyright © 2023. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interest Statement YP is the founding member of the Sub2 marathon project (www.sub2hrs.com). All other authors have no conflicts of interest relevant to the content of this article.

Auteurs

M J Stacey (MJ)

Academic Department of Military Medicine, Defence Medical Services, UK; Carnegie School of Sport, Leeds Beckett University, UK; Department of Surgery and Cancer, Imperial College London, UK. Electronic address: m.stacey13@imperial.ac.uk.

T Leckie (T)

School of Sport and Health Sciences, University of Brighton, UK.

D Fitzpatrick (D)

School of Sport and Health Sciences, University of Brighton, UK; Sport and Exercise Medicine Department, Charing Cross Hospital, UK.

L Hodgson (L)

Brighton & Sussex Medical School, Brighton, UK.

A Barden (A)

School of Medicine, Imperial College London, UK.

R Jenkins (R)

Foundation Programme, Defence Medical Services, UK.

R Galloway (R)

Brighton & Sussex Medical School, Brighton, UK.

C Weller (C)

Brighton & Sussex Medical School, Brighton, UK.

G V Grivas (GV)

Division of Humanities and Political Sciences, Physical Education and Sports, Hellenic Naval Academy, Greece.

Y Pitsiladis (Y)

School of Sport and Health Sciences, University of Brighton, UK; Human Telemetrics, UK.

A J Richardson (AJ)

School of Sport and Health Sciences, University of Brighton, UK.

D R Woods (DR)

Academic Department of Military Medicine, Defence Medical Services, UK; Carnegie School of Sport, Leeds Beckett University, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH